Thursday, May 2, 2024

Medications Found To Cause Long Term Cognitive Impairment Of Aging Brain,...

Drugs commonly taken for a variety of common medical conditions including insomnia, allergies, or incontinence negatively affect the brain causing long term cognitive impairment in older African-Americans, according to a study appearing in the July 13, 2010 print issue of Neurology, the medical journal of the American Academy of Neurology.

Risks: Acid Reflux Drugs Tied To Bone Fractures

A new analysis adds to growing evidence that people using proton pump inhibitors to control symptoms of acid reflux are more likely to fracture bones than those who do not. The analysis did not find a similar increase in fracture risk among patients taking older acid reflux medications, called histamine-2 receptor antagonists.

Medication Expiration Dates Cheat Consumers: Lawsuit

Have you ever tossed an expensive bottle of prescription or over-the-counter drugs because they had “expired”? A class action lawsuit claims these dates are basically bogus, made up to goose replacement sales by drug makers who know the drugs are good for years, even decades, after the “use by” date.

Long Term Use Of Oral Bisphosphonates May Double Risk Of Esophageal...

People who take oral bisphosphonates for bone disease over five years may be doubling their risk of developing oesophageal cancer (cancer of the gullet), according to a new study published online in the British Medical Journal.

Heart Attack Risk Of Diabetes Drug: Experts Call For Avandia To...

A diabetes drug taken by up to 100,000 patients increases the risk of heart attacks and should be withdrawn on safety grounds, senior doctors say today. A report by the British Medical Journal says Avandia should never have been licensed in Britain because its risks outweigh its benefits. One UK expert has calculated that the drug may cause as many as 1,000 extra heart attacks a year in Britain.

A Prescription for Fear

If you’re looking for the name of a new pill to “ask your doctor about,” as the ads say, the Mayo Clinic Health Information...

Antidepressants, Sleeping Pills And Anxiety Drugs May Increase Driving Risk

Drugs prescribed to treat anxiety, depression and insomnia may increase patients' risk of being involved in motor vehicle accidents, according to a recent study, published in the British Journal of Clinical Pharmacology. Based on the findings, the researchers suggested doctors should consider advising patients not to drive while taking these drugs.

Cholesterol-Lowering Drugs May Be Linked To Increased Cataract Risk

Patients using cholesterol-lowering statin drugs may be at increased risk of developing age-related cataracts, according to a study -- "Age-related Cataract Is Associated with Type 2 Diabetes and Statin Use," in the August issue of Optometry and Vision Science, official journal of the American Academy of Optometry.

Acid Suppressive Medication May Increase Risk Of Pneumonia

Using acid suppressive medications, such as proton pump inhibitors and histamine2 receptor antagonists, may increase the risk of developing pneumonia, states an article in CMAJ (Canadian Medical Association Journal).

Drug Expiration Dates – Do They Mean Anything?

With a splitting headache you reach into your medicine cabinet for some aspirin only to find the stamped expiration date on the bottle has passed - two years ago. So, do you take it or don't you? If you decide to take the aspirin will it be a fatal mistake or will you simply continue to suffer from the headache?

X-Rays Help Predict Permanent Bone Damage From Bisphosphonates

Breast cancer patients, individuals at risk for osteoporosis and those undergoing certain types of bone cancer therapies often take drugs containing bisphosphonates. These drugs have been found to place people at risk for developing osteonecrosis of the jaws (a rotting of the jaw bones). Dentists, as well as oncologists, are...

Astellas Bladder Treatment Wins U.S. Approval For Sale

The Food and Drug Administration cleared the drug, mirabegron, to treat the need to frequently or involuntarily urinate, the agency said today in a statement. The drug enhances bladder storage without affecting patients’ ability to urinate like others on the market. Tokyo-based Astellas will market the treatment as Myrbetriq, the FDA said.